GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

bamlanivimab   Click here for help

GtoPdb Ligand ID: 11325

Synonyms: LY-3819253 | LY-CoV555 | LY3819253
Compound class: Antibody
Comment: Bamlanivimab is a monoclonal antibody against the surface spike protein of SARS-CoV-2. It was developed by Eli Lilly, but such is the speed of COVID-19 therapeutic development, there are no peer-reviewed articles that report its design, preclinical or early clinical data.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV Spike glycoprotein SARS-CoV-2 Antibody Binding - - -
⤷